BLSM (BLSM) Stock Price & Analysis
BLSM (BLSM) rose 9.94% to USD 22.01 as of September 8, 2026 at 13:15 UTC, according to Nexqual real-time market data.
BLSM last closed at USD 22.01; the session ranged USD 19.36–22.16 on volume of 168,706 shares. Market capitalization is —, with a 52-week range of USD 15.25–22.16 (NMS). Source: Nexqual, September 8, 2026 at 13:15 UTC.
Key Statistics (as of September 8, 2026 at 13:15 UTC)
| Price | USD 22.01 |
|---|---|
| Change | ▲ 9.94% (up) |
| Previous Close | USD 22.01 |
| Open | USD 22.01 |
| Day Range | USD 19.36 – 22.16 |
| 52-Week Range | USD 15.25 – 22.16 |
| Volume | 168,706 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BLSM)
Nexqual's technical model rates BLSM "SELL" based on 2 bullish and 3 bearish signals across 21 daily candles, as of September 8, 2026 at 13:15 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 77.05 (overbought) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LTGO | Latigo Biotherapeutics, Inc. | USD 23.04 | ▲ 5.83% |
| BRVE | Braveheart Bio, Inc. | USD 26.74 | ▼ 0.78% |
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| EIKN | Eikon Therapeutics, Inc. | USD 10.86 | ▼ 4.57% |
| ODTX | Odyssey Therapeutics, Inc. | USD 28.76 | ▲ 8.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:15 UTC. This page is informational and not investment advice.